Gates Foundation Joins Radiant Bio’s $35M Round for Antibody Drugs With ‘Better Grip’
An antibody drug is only as good as its ability to connect to its target. Sometimes a mutation at the ...
An antibody drug is only as good as its ability to connect to its target. Sometimes a mutation at the ...
(Reuters) -Johnson & Johnson reported a first-quarter profit above Wall Street estimates on Tuesday, helped by strong sales of its ...
Wheel, a virtual care platform, has added three companies to its integrated virtual care ecosystem: prescription drug company Mark Cuban ...
A blockbuster Amgen antibody that treats bone conditions is set to face its first biosimilar competition. The FDA on Tuesday ...
That is the topic of a U.S. Senate hearing last week. One person testifying was ...
North Carolina is cutting off coverage of anti-obesity medications for state employees, citing soaring costs and a lack of agreement ...
Dyne Therapeutics started the new year with proof-of-concept clinical data for experimental genetic medicines addressing two rare muscle diseases—one of ...
I just came across a nice overview article titled The financial ecosystem of pharmaceutical R&D. The white paper was developed ...
Copyright © 2024 The Israel Chronicle News.
The Israel Chronicle News is not responsible for the content of external sites.